PCN19 AUSTRALIAN COST-EFFECTIVENESS ANALYSIS OF ANASTROZOLEVSTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL

Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67257-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)67257-9/fulltext
Section Title :
Section Order : 484
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67257-9&doi=10.1016/S1098-3015(10)67257-9
HEOR Topics :
Tags :
Regions :